Cynomolgus Monkey Endometriosis Model For Advancing Therapeutic Research

The fourth Saturday of March marks "World Endometriosis Day," an annual event dedicated to raising awareness about Endometriosis(EMT), a prevalent condition affecting millions of women globally.

Endometriosis is characterized by the presence of endometrial-like tissue outside the uterus. This ectopic tissue undergoes growth, proliferation, and induces inflammatory responses, leading to a spectrum of debilitating symptoms including chronic pelvic pain, dysmenorrhea, dyspareunia, and potentially infertility and reduced fertility, significantly impacting women's quality of life and overall well-being.

The etiology of endometriosis remains incompletely understood, involving a complex interplay of genetic, immunological, and endocrine factors. This complexity poses substantial challenges to the development of novel and effective therapies. Current clinical treatments are limited, highlighting the urgent need for improved therapeutic strategies to alleviate patient suffering.

To effectively combat endometriosis, global research efforts are continuously underway. However, ethical considerations and complexities inherent in clinical studies limit in-depth and comprehensive investigations in human patients. In this context, the development of high-quality animal models is paramount, serving as essential tools for unraveling disease mechanisms and validating therapeutic interventions.

Animal models, in essence, are scientific tools that simulate the onset, progression, and resolution of human diseases in laboratory animals. An ideal animal model should closely mimic the pathological features, physiological alterations, and clinical manifestations of the human disease. Utilizing animal models enables researchers to:

• Investigate Disease Pathogenesis: Conduct systematic studies under controlled experimental conditions to elucidate the mechanisms underlying disease development, revealing potential etiological factors and pathological processes such as inflammatory responses, angiogenesis, and abnormal nerve innervation.
• Evaluate Novel Therapies: Efficiently and cost-effectively assess potential therapeutic strategies, including novel drugs, biologics, and surgical approaches, during the preclinical phase. This allows for the identification of promising candidates and accelerates the drug development pipeline.
• Guide Clinical Practice: Optimize clinical treatment protocols through animal model studies, including drug dosage optimization, administration routes, and combination therapy strategies, to enhance therapeutic efficacy and improve patient outcomes.

Among various experimental animals, non-human primates (NHPs), particularly Cynomolgus monkeys ( Macaca fascicularis), are highly valued in endometriosis research due to their significant physiological, genetic, immunological, and menstrual cycle similarities to humans. While spontaneous endometriosis occurs at a low rate in Cynomolgus monkeys, experimentally induced models can be effectively generated to facilitate in-depth research.

Prisys Biotech: Delivering High-Quality Cynomolgus Monkey Endometriosis Models

Prisys Biotech, a company specializing in non-human primate animal models, possesses extensive expertise in NHP model development and disease research. Employing the classic surgical autotransplantation method, coupled with optimized endometrial tissue inoculation techniques, we have successfully established a high-quality, stable Cynomolgus monkey endometriosis model.

The surgical autotransplantation method utilized by Prisys Biotech centers on the principle of transplanting a Cynomolgus monkey's own endometrial tissue, via precise surgical procedures, to ectopic locations such as the peritoneal surfaces of the pelvis and ovaries, mimicking the pathogenesis of endometriosis. To enhance model success rates and the stability of disease phenotypes, we have optimized key procedural steps:

• Standardized Tissue Harvesting: Rigorous control over the endometrial tissue collection site and timing ensures the viability and homogeneity of the harvested tissue.
• Optimized Inoculation Technique: Employing refined tissue inoculation methods enhances the survival rate of transplanted tissue and its ability to grow ectopically.
• Post-operative Management: Implementing meticulous post-operative care minimizes surgical trauma, promotes animal recovery, and facilitates close monitoring of model disease progression.

Key Advantages of the Prisys Biotech Endometriosis Model

• High Model Reliability: Utilizing the internationally recognized surgical autotransplantation method in conjunction with Prisys Biotech's optimized technical protocols results in high model generation success rates. Stable ectopic lesion formation and reproducible disease phenotypes are consistently achieved. The model undergoes rigorous pathological assessment and imaging validation to ensure authenticity and reliability.
• Physiological Relevance: Cynomolgus monkeys exhibit high physiological homology to human females, particularly in reproductive physiology and endocrine systems. The model closely mimics the development and progression of human endometriosis, including the formation of ectopic lesions, hormone dependence, and key pathological features such as inflammatory responses.
• High Research Application Value: The model is suitable for long-term observation and diverse intervention studies, enabling in-depth investigations into the pathogenesis and pathophysiology of endometriosis. It provides a robust preclinical research platform for novel drug development and therapeutic evaluation. The model is applicable for assessing various therapeutic strategies including targeted therapies, immunotherapies, and gene therapies.

If you are engaged in the following cutting-edge research areas, Prisys Biotech's high-quality Cynomolgus monkey endometriosis model will be your ideal partner in accelerating your research progress and achieving groundbreaking discoveries:

• Innovative Drug Efficacy Evaluation: Comprehensive assessment of the therapeutic effects of novel small molecule drugs, antibody-based therapeutics, and cell therapies for endometriosis, including lesion regression, symptom alleviation, long-term efficacy, and safety profiles. The model can be used to investigate drugs targeting endometriosis-specific molecules, modulating the inflammatory microenvironment, and inhibiting angiogenesis.
• In-depth Mechanistic Studies: Leveraging the model to delve into the complex pathogenesis of EMT, including genetic susceptibility, epigenetic modifications, immune dysregulation, and endocrine disruption. This aims to uncover key molecules and signaling pathways involved in disease development, providing a theoretical basis for developing more precise therapeutic targets. Examples include research on endometriosis stem cell characteristics, the role of microRNAs in the disease, and the relationship between the gut microbiome and EMT.
• Exploration of Fertility Impact and Interventions: In-depth investigation of the mechanisms by which EMT impairs female fertility, such as impaired ovarian function, fallopian tube dysfunction, and reduced endometrial receptivity. The model can be used to evaluate the effectiveness of fertility-protective drugs, assisted reproductive technologies, and other interventions, providing experimental evidence for improving the treatment of EMT-associated infertility.

Contact Prisys Biotech Today to Initiate Your Endometriosis Research Breakthrough

Research into endometriosis is a complex and ongoing endeavor. Overcoming this women's health challenge requires collaborative efforts. Prisys Biotech is committed to providing high-quality Cynomolgus monkey endometriosis models, expert technical support, and comprehensive research services to empower your breakthroughs in endometriosis research and contribute to the well-being of women worldwide.